Trevena
TRVN
#10608
Rank
HK$0.08 M
Marketcap
HK$0.09341
Share price
0.00%
Change (1 day)
-99.25%
Change (1 year)

Revenue for Trevena (TRVN)

Revenue in 2024 (TTM): HK$4.25 Million

According to Trevena's latest financial reports the company's current revenue (TTM ) is HK$4.25 Million. In 2023 the company made a revenue of HK$24.4 Million an increase over the revenue in the year 2022 that were of -HK$3.27 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Trevena from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) HK$4.25 M-82.57%
2023 HK$24.4 M-847.3%
2022 -HK$3.27 Million-173.87%
2021 HK$4.42 M-81.42%
2020 HK$23.79 M9754.34%
2019 HK$0.24 M-99.46%
2018 HK$44.88 M
2017 N/A-100%
2016 HK$29.07 M-39.97%
2015 HK$48.44 M
2014 N/A-100%
2013 HK$1.04 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
HK$280.01 B 6,587,995.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
HK$0.67 B 15,872.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
HK$55.55 M 1,207.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$500.03 B 11,764,552.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
HK$2.9 M-31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
HK$5.06 M 19.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
HK$0.78 B 18,288.28%๐Ÿ‡บ๐Ÿ‡ธ USA